Lyrica CR 165 mg/1 (Pregabalin TABLET, FILM COATED, EXTENDED RELEASE) 165 mg/1

Lyrica CR 165 mg is an extended-release tablet containing pregabalin, used for managing certain types of nerve pain and seizures. This medication is designed for oral administration and is manufactured by Parke-Davis, a division of Pfizer Inc.

Strength

165 mg/1

Pack Size

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0071-1027-01)

Manufacturer / TM Owner

Parke-Davis Div of Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lyrica CR 165 mg is primarily used for the management of neuropathic pain and as an adjunctive therapy for partial seizures. Pregabalin, the active ingredient, is often prescribed for conditions involving nerve damage or dysfunction, which may lead to chronic pain. Patients may wonder, 'What is Lyrica CR used for?' This medication is specifically formulated to provide extended relief, helping to maintain consistent levels of the drug in the body.

Side Effects

Common effects of Lyrica CR 165 mg may include dizziness, drowsiness, and peripheral edema. Some users might experience weight gain or blurred vision. These effects can vary among individuals and may not affect everyone who takes the medication. It's important to monitor how the body responds to this extended-release formulation.

Precautions & Warnings

Lyrica CR 165 mg should be handled with care, especially for those with a history of heart or kidney issues. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid activities that require alertness, such as driving, until they know how the medication affects them.

Avoid Interactions

Lyrica CR 165 mg may interact with alcohol and other central nervous system depressants, potentially enhancing sedative effects. It is also important to be cautious when combining this medication with opioids or other drugs that affect the central nervous system. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Lyrica CR is used for managing neuropathic pain and as an adjunctive therapy for partial seizures.

Lyrica CR 165 mg is designed for oral administration and should be taken as directed by a healthcare professional.

Common side effects may include dizziness, drowsiness, and peripheral edema.

Lyrica CR may interact with alcohol and other central nervous system depressants, so it's important to consult a healthcare provider before combining medications.

Lyrica CR should be used with caution in individuals with a history of heart or kidney issues, and it's important to follow the prescribed dosage.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.